Literature DB >> 8782594

"NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms.

L K Keefer1, R W Nims, K M Davies, D A Wink.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8782594     DOI： 10.1016/s0076-6879(96)68030-6

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  173 in total

1.  Effects of nitric oxide donors on cardiac contractility in wild-type and myoglobin-deficient mice.

Authors:  J W Wegener; A Gödecke; J Schrader; H Nawrath
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

2.  Nitric oxide preferentially induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor beta 2 expression via cGMP.

Authors:  Wanda Niedbala; Xiao-Qing Wei; Carol Campbell; Duncan Thomson; Mousa Komai-Koma; Foo Y Liew
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-25       Impact factor: 11.205

3.  Bystander effect on cell growth stimulation in neoplastic HSGc cells induced by heavy-ion irradiation.

Authors:  Chunlin Shao; Mizuho Aoki; Yoshiya Furusawa
Journal:  Radiat Environ Biophys       Date:  2003-08-15       Impact factor: 1.925

4.  Nitric oxide is consumed, rather than conserved, by reaction with oxyhemoglobin under physiological conditions.

Authors:  Mahesh S Joshi; T Bruce Ferguson; Tae H Han; Daniel R Hyduke; James C Liao; Tienush Rassaf; Nathan Bryan; Martin Feelisch; Jack R Lancaster
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-17       Impact factor: 11.205

Review 5.  Local delivery of nitric oxide: targeted delivery of therapeutics to bone and connective tissues.

Authors:  Scott P Nichols; Wesley L Storm; Ahyeon Koh; Mark H Schoenfisch
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

6.  A hybrid biomimetic nanomatrix composed of electrospun polycaprolactone and bioactive peptide amphiphiles for cardiovascular implants.

Authors:  Adinarayana Andukuri; Meenakshi Kushwaha; Ajay Tambralli; Joel M Anderson; Derrick R Dean; Joel L Berry; Young Doug Sohn; Young-Sup Yoon; Brigitta C Brott; Ho-Wook Jun
Journal:  Acta Biomater       Date:  2010-08-20       Impact factor: 8.947

7.  A system for exposing molecules and cells to biologically relevant and accurately controlled steady-state concentrations of nitric oxide and oxygen.

Authors:  Vasileios Dendroulakis; Brandon S Russell; C Eric Elmquist; Laura J Trudel; Gerald N Wogan; William M Deen; Peter C Dedon
Journal:  Nitric Oxide       Date:  2012-06-21       Impact factor: 4.427

8.  Prolonged treatment of porcine pulmonary artery with nitric oxide decreases cGMP sensitivity and cGMP-dependent protein kinase specific activity.

Authors:  William J Perkins; David O Warner; Keith A Jones
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-10-24       Impact factor: 5.464

9.  Cell-permeable esters of diazeniumdiolate-based nitric oxide prodrugs.

Authors:  Harinath Chakrapani; Anna E Maciag; Michael L Citro; Larry K Keefer; Joseph E Saavedra
Journal:  Org Lett       Date:  2008-10-29       Impact factor: 6.005

10.  Enhanced anti-inflammatory potency of a nitric oxide-releasing prednisolone derivative in the rat.

Authors:  Fusun Turesin; Piero del Soldato; John L Wallace
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.